Detalles de la búsqueda
1.
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.
J Transl Med
; 21(1): 75, 2023 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36737752
2.
Oligometastatic prostate cancer treatment.
Future Oncol
; 17(29): 3893-3899, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34296622
3.
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.
Eur J Nucl Med Mol Imaging
; 47(11): 2633-2638, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32249345
4.
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
J Transl Med
; 17(1): 296, 2019 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464635
5.
Abiraterone acetate treatment in patients with castration-resistant prostate cancer with visceral metastases: a real-world experience.
Anticancer Drugs
; 30(2): 179-185, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30320608
6.
Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer.
Future Oncol
; 15(10): 1115-1123, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30887825
7.
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma.
Anticancer Drugs
; 29(7): 705-709, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846246
8.
Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program.
Future Oncol
; 14(26): 2691-2699, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30207488
9.
Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: the prospective observational scoop trial results.
Anticancer Drugs
; 28(1): 104-109, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27579728
10.
ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review.
Int J Med Sci
; 14(6): 554-559, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28638271
11.
Testicular and testicular adnexa tumors in the elderly.
Anticancer Drugs
; 24(3): 228-36, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23059385
12.
Unilateral post-chemotherapy robot-assisted retroperitoneal lymph node dissection in Stage II non-seminomatous germ cell tumor: A tertiary care experience.
Asian J Urol
; 10(4): 440-445, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38024429
13.
Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors.
Cancers (Basel)
; 15(23)2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38067406
14.
The role of immunotherapy treatment in non-clear cell renal cell carcinoma: An analysis of the literature.
Crit Rev Oncol Hematol
; 188: 104036, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37263397
15.
Feasibility of cabazitaxel in octogenarian prostate cancer patients.
Curr Urol
; 17(3): 153-158, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37448615
16.
Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.
Ther Adv Med Oncol
; 15: 17588359231156147, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895852
17.
Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.
Front Oncol
; 13: 1270498, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38023175
18.
First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry.
Tumori
; 109(2): 224-232, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35400269
19.
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy.
Curr Oncol
; 29(7): 4578-4586, 2022 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35877222
20.
Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife® System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity®: Outcomes, Toxicities and Dosimetric Evaluation.
Cancers (Basel)
; 14(13)2022 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35804958